Company page
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. is a public company traded under the ticker ASMB in the American market. The company has a market capitalization of approximately $484.3 million. Assembly Biosciences focuses on developing innovative therapies for viral infections, particularly hepatitis B.
- Ticker
- ASMB:NASDAQ
- Asset type
- Stock
- Market cap
- $484.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD